Stefan N Constantinescu

26PUBLICATIONS
82CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursMedical mycologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 24, 2026
Selective dependency of CALR-mutant myeloproliferative neoplasms on TYK2 signaling.

|Jan 09, 2026
Next-generation JAK inhibitors in the treatment of myeloproliferative neoplasms.

Stefan N Constantinescu, William Vainchenker, Christian Pecquet

|May 07, 2025
Delineating Mpl-dependent and -independent phenotypes of Jak2 V617F-positive MPNs in vivo.

Nicolas Papadopoulos, Audrey Nédélec, Yacine Rahmani

|Feb 28, 2025
LIBX-A401: A Novel Selective Inhibitor of Acyl-CoA Synthetase Long Chain Family Member 4 (ACSL4) and Its Binding Mode.

Darius Mazhari Dorooee, Séverine Ravez, Didier Vertommen

|Apr 17, 2024
Novel germline JAK2R715T mutation causing PV-like erythrocytosis in 3 generations. Amelioration by Ropeg-Interferon.

Jihyun Song, Lucie Lanikova, Soo Jin Kim

|Aug 24, 2023
Modulation of human thrombopoietin receptor conformations uncouples JAK2 V617F-driven activation from cytokine-induced stimulation.

Nicolas Papadopoulos, Ajda Pristavec, Audrey Nédélec

Pageof 5

Frequent Collaborators

8 joint publications

Nicolas Papadopoulos

6 joint publications

Christian Pecquet

5 joint publications

William Vainchenker

4 joint publications

Gabriel Levy